Teradyne, Inc (TER) stock analysis
Close on Nov 11, 2026Market cap $41.49BP/E 30.5Yield 0.18%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid21 of 30 checks passed
Teradyne passes 21 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 3/6
- Past performance
- 5/6
- Financial health
- 6/6
- Dividend
- 3/6
What stands out
Trading below fair value
The share price of $265.78 is below our fair value estimate of $284.52.
Return on equity over 15%
Return on equity was 42.9% over the last twelve months and averaged 25.8% over five years.
Return on capital over 10%
Return on invested capital was 47.3%, above the 10% that usually covers the cost of capital.
No debt
Teradyne has no borrowings on its latest balance sheet.
What to watch
Margin of safety under 20%
The price is 6.6% below fair value, less than the 20% cushion we look for.
Earnings shrank over 5 years
Net income shrank 6.7% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 0.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -6.3% a year over the last three fiscal years.
Valuation4/6
P/E below its 5-year median
Teradyne's P/E of 30.5 is below its own 5-year median of 30.9.
P/E below the industry
Teradyne's P/E of 30.5 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA below its 5-year median
Teradyne's EV/EBITDA of 23.5 is below its 5-year median of 24.8.
P/B above the industry
Teradyne's price-to-book of 11.25 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading below fair value
The share price of $265.78 is below our fair value estimate of $284.52.
Margin of safety under 20%
The price is 6.6% below fair value, less than the 20% cushion we look for.
Growth3/6
Revenue growing under 10% a year
Revenue grew 0.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -6.3% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 210% over the last twelve months, against a 5-year average of -6.7% a year.
Growing faster than the industry
Revenue grew 74.9% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance issued
The latest outlook (fourth quarter of 2026 revenue, Oct 28, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 59.3% over the last twelve months, against 58.9% a year earlier.
Past performance5/6
Return on equity over 15%
Return on equity was 42.9% over the last twelve months and averaged 25.8% over five years.
Return on capital over 10%
Return on invested capital was 47.3%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Teradyne's return on equity of 42.9% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings shrank over 5 years
Net income shrank 6.7% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 27.5% over the last twelve months, against a 5-year average of 20.7%.
Net margin above the industry
Teradyne's net margin of 27.5% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health6/6
No debt
Teradyne has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
Operating income covers interest expense 147.1 times.
Short-term assets cover short-term debts
Current assets are 2.08 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 17.17; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Teradyne paid dividends worth 0.2% of the share price over the last twelve months.
Yield below Treasuries
The 0.2% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Teradyne yields 0.2%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Covered by earnings
Dividends take 5.8% of net income.
Covered by free cash flow
Dividends take 7.8% of free cash flow.
Fair value
How we estimate itOur estimate per share
$284.52
The share price is 7% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 33.7× | 30.9× | 36.5× | $293.42 | 53% |
| EV/EBITDA | 24.3× | 24.8× | 23.7× | $274.36 | 47% |
| Earnings powerleft out, too far from the others | 13.4% cost of equity | – | – | $25.05 | – |
| Fair value | $284.52 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 30.9
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $1.20B
- Value traded per 1% price move
- $301.56M
Downside
High risk
- Typical loss in a bad month
- 37.6%
- Volatility (annualized)
- 79%
- Sharpe ratio, 1 year
- 0.51
- Beta to the S&P 500 (5Y)
- 1.71
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +13.1% | +0.4% | +0.4% | +6.9% | |
| Gross profit | +12.6% | -0.2% | +0.8% | +7.3% | |
| Operating income | +9.5% | -7.9% | -6.9% | +10.3% | |
| Net income | +2.2% | -8.2% | -6.7% | +10.4% | |
| EPS, diluted | +4.5% | -6.3% | -4.1% | +13.6% | |
| Free cash flow | -5.0% | +2.8% | -8.0% | +3.1% | |
| Dividend per share | 0.0% | +2.9% | +3.7% | +7.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -2.3% | 42.5% | 19.7% | |
| Return on assets | -1.6% | 24.4% | 14.0% | |
| Current ratio | 4.36 | 3.45 | 1.75 | |
| Interest coverage | -17.3× | 38.4× | 95.0× | |
| Inventory turnover | 5.5× | 6.4× | 3.9× | |
| Capex to revenue | 4.9% | 5.9% | 7.0% | |
| Diluted shares | 203M | 183M | 160M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Teradyne generated $3.61B from operations and spent $3.88B on capital expenditure, dividends and share buybacks. 23% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 17.4% | 0.81× | 1.41× | 19.7% |
| FY2024 | 19.2% | 0.78× | 1.35× | 20.3% |
| FY2023 | 16.8% | 0.77× | 1.40× | 18.0% |
| FY2022 | 22.7% | 0.86× | 1.46× | 28.5% |
| FY2021 | 27.4% | 0.99× | 1.56× | 42.5% |
| FY2020 | 25.1% | 0.97× | 1.75× | 42.5% |
| FY2019 | 20.4% | 0.84× | 1.83× | 31.1% |
| FY2018 | 21.5% | 0.72× | 1.67× | 26.0% |
| FY2017 | 12.1% | 0.73× | 1.55× | 13.6% |
| FY2016 | -2.5% | 0.66× | 1.40× | -2.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$554.05M
- Cash generatingOperating cash flow above zero$674.42M
- Return on assets improvedROA up on the prior year15.6% → 14.9%
- Earnings backed by cashOperating cash flow above net income$674.42M vs $554.05M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.91 → 1.75
- No dilutionShare count did not rise163M → 160M
- Gross margin improvedGross margin up on the prior year58.48% → 58.22%
- More efficientAsset turnover rose0.81 → 0.86
See a number that looks wrong?